C
SANA icon

Covestor’s Sana Biotechnology SANA Stock Holding History

Covestor’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
87
+61
+235% +$197 ﹤0.01% 2798
2026
Q1 		$0 Buy
26
+1
+4% +$4 ﹤0.01% 2710
2025
Q4 		$0 Sell
25
-1
-4% -$4 ﹤0.01% 2679
2025
Q3 		$0 Hold
26
– – ﹤0.01% 2706
2025
Q2 		$0 Sell
26
-2
-7% -$4 ﹤0.01% 2682
2025
Q1 		$0 Buy
28
+1
+4% +$3 ﹤0.01% 2664
2024
Q4 		$0 Buy
27
+13
+93% +$39 ﹤0.01% 2672
2024
Q3 		$0 Sell
14
-1
-7% -$5 ﹤0.01% 2688
2024
Q2 		$0 Hold
15
– – ﹤0.01% 2685
2024
Q1 		$0 Sell
15
-14
-48% -$105 ﹤0.01% 2667
2023
Q4 		$0 Buy
29
+10
+53% +$37 ﹤0.01% 2641
2023
Q3 		$0 Sell
19
-2
-10% -$11 ﹤0.01% 2631
2023
Q2 		$0 Sell
21
-1
-5% -$6 ﹤0.01% 2580
2023
Q1 		$0 Hold
22
– – ﹤0.01% 2506
2022
Q4 		$0 Sell
22
-1
-4% -$5 ﹤0.01% 2526
2022
Q3 		$0 Sell
23
-5
-18% -$36 ﹤0.01% 2510
2022
Q2 		$0 Sell
28
-7
-20% -$45 ﹤0.01% 2304
2022
Q1 		$0 Buy
35
+3
+9% +$24 ﹤0.01% 2404
2021
Q4 		$1K Buy
+32
New +$617 ﹤0.01% 1913

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Covestor's SANA Position: Q2 2026 in Review

Covestor increased its Sana Biotechnology (SANA) stake by 235% in Q2 2026, buying an estimated $197 and bringing the position to 87 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2798.

Covestor first reported a position in SANA in Q4 2021 and has held it in 19 quarters since. The position peaked at $1K in Q4 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Covestor held 87 shares of Sana Biotechnology worth $0 as of Q2 2026.
  • Covestor bought 61 Sana Biotechnology shares in Q2 2026, an estimated $197.
  • Sana Biotechnology made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2798 holding.
  • Covestor first reported a position in Sana Biotechnology in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Sana Biotechnology position peaked at $1K in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.